p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index, and 1 are not checked yet; 7 of the 38 sources its claims cite were checked for support.
Abstract
Cellular senescence is a permanent state of cell cycle arrest that protects the organism from tumorigenesis and regulates tissue integrity upon damage and during tissue remodeling. However, accumulation of senescent cells in tissues during aging contributes to age‐related pathologies. A deeper understanding of the mechanisms regulating the viability of senescent cells is therefore required. Here, we show that the CDK inhibitor p21 (CDKN1A) maintains the viability of DNA damage‐induced senescent cells. Upon p21 knockdown, senescent cells acquired multiple DNA lesions that activated ataxia telangiectasia mutated (ATM) and nuclear factor (NF)‐κB kinase, leading to decreased cell survival. NF‐κB activation induced TNF‐α secretion and JNK activation to mediate death of senescent cells in a caspase‐ and JNK‐dependent manner. Notably, p21 knockout in mice eliminated liver senescent stellate cells and alleviated liver fibrosis and collagen production. These findings define a novel pathway that regulates senescent cell viability and fibrosis.
Verified 2026-10-05 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
p21 (CDKN1A) is required to maintain the viability of DNA damage-induced senescent cells, and its loss triggers ATM/NF-κB/TNF-α/JNK signaling and caspase-dependent death. In mice, p21 knockout reduces senescent cells in fibrotic liver and alleviates liver fibrosis.
Key findings
- p21 knockdown selectively killed DNA damage-induced senescent (DIS) cells: 30% death in IMR-90 DIS cells, 26% reduction in DIS MEFs, 54% reduction in DIS BJ cells, and 60% lower viability in p21−/− MEFs versus WT; H1299 cells showed 75% reduction after p21 shRNA and etoposide.
- p21 knockdown in DIS cells intensified the DNA damage response (increased p-ATM, p-CHK2, γH2AX, p53), resumed DNA synthesis (BrdU incorporation), caused fragmented chromosomes/micronucleation, and increased sub-G1; microarrays showed 1,595 unique genes changed versus 82 in growing cells, with TNF-α mRNA increased 30-fold.
- Death after p21 knockdown was caspase- and JNK-dependent: pan-caspase inhibitor QVD only partially rescued viability (17% increase), while combined QVD plus JNK inhibitor or JNK knockdown completely rescued; p65 knockdown blocked TNF-α production but did not rescue death.
- In CCl4-treated mice, p21−/− livers had significantly fewer senescent cells, detectable apoptotic cells, reduced Sirius Red fibrosis, and lower TGF-β, COL1A1, and α-SMA expression; p21 knockdown also reduced COL1A1 mRNA by 48% at 24 h before cell death.
Methods
- In vitro senescence models used human IMR-90 and BJ fibroblasts, mouse embryonic fibroblasts, and H1299 cells; DIS was induced with etoposide (20 μM for MEFs/H1299, 50 μM for BJ/IMR-90) for 48 h, and OIS with H-RasV12. p21, p53, pRb, p65, or JNK1 were knocked down by siRNA/shRNA; viability was measured with PrestoBlue, with QVD, z-VAD, or SP600125 treatments where indicated.
- Molecular analyses included Affymetrix PrimeView microarrays (3 replicates) with WikiPathways/IPA enrichment, RT–PCR, immunoblotting, immunofluorescence, comet assay, BrdU incorporation, cell cycle flow cytometry, and ImageStreamX γH2AX foci quantification.
- In vivo, WT and p21−/− 8-week-old female mice received CCl4 for 6 weeks (n = 10 per group); livers were analyzed by SA-β-gal, cleaved caspase-3, Sirius Red, and RT–PCR. Statistical significance used Student’s t-test with P < 0.05.
Limitations
- The paper states that direct regulation of JNK phosphorylation and caspases by p21 cannot be excluded, and that further research is required to define the mode of cell death after p21 knockdown (e.g., necrotic or autophagic versus apoptotic).
- The paper states that mice were assigned to experimental groups by genotype without randomization or blinding.
- Evident from the text: the in vitro work relies mainly on fibroblast lines and one cancer line, and the in vivo work is limited to CCl4-induced liver fibrosis in female mice, so generalizability to other senescent cell types, tissues, and aging models is not established; the paper also notes multiple possible mechanisms for fibrosis alleviation that were not fully distinguished.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
4 Valid · 0 Not valid · 21 Not checked · 85 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Senescent cell elimination can indeed increase the proliferative capacity of stem cells and hence support tissue regeneration”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Chang et al, 2016 matched to “Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice” (2016) source
The Abstract (Results/Discussion passages) states that ABT263-mediated clearance of senescent cells 'significantly improved the clonogenicity (Fig. 3c) and long-term engraftment ability of irradiated HSCs' and that in normally aged mice it 'improved the clonogenicity of isolated MuSCs', with the authors concluding that 'selective clearance of SCs by a pharmacological agent is beneficial in part through its rejuvenation of aged tissue stem cells'. The passage on mechanism ('clearance of senescent HSCs by ABT263 treatment can promote the expansion of normal HSC clones') directly supports increased stem-cell proliferative capacity, and restored long-term repopulation/multilineage engraftment supports the regenerative consequence, in mice (HSCs and MuSCs). (LLM, conf=0.85)
- Supportedcites Yosef et al, 2016 matched to “Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL” (2016) source
The Abstract states that 'Elimination of senescent cells from the epidermis leads to an increase in hair-follicle stem cell proliferation', and the Results (ABT-737 eliminates p53-induced senescent cells from skin) report increased Ki67+ and CD34+/CD49fhigh bulge stem cells that 'repopulate the stem cell compartment'. The Discussion extends this to regeneration: 'these findings suggest that the clearance of senescent cells can lead to tissue renewal and improved fitness', with relevance to other tissues (haematopoietic system, ref 42) noted. The claim's hedged modality ('can') matches the source; the only caveat is that the evidence is in mouse epidermis and the authors explicitly did not observe prominent hair regrowth within their time frame. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These cells use autophagy for their maintenance”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Partly supportedcites Young et al, 2009 matched to “Autophagy mediates the mitotic senescence transition” (2009) sourceExperimental — accuracy not yet measured
Our copy confirms that senescent cells run elevated autophagy (Results, LC3-II accumulation and increased long-lived-protein degradation in Ras/MEK senescent IMR90, BJ and embryonic fibroblasts, with intact autophagic flux) and that autophagy is functionally required for the senescence phenotype, including IL6/IL8 production (Results and Discussion, Fig. 4D-E). But the source frames this as mediating the ACQUISITION/ESTABLISHMENT of senescence — 'important for the rapid protein remodelling required to make the efficient transition from a proliferative to a senescent state' (Introduction) — and it explicitly tested the maintenance idea and found against it: 'knockdown of ATG5/7 in established ras senescent BJ cells failed to reverse the senescence arrest... autophagy contributes to, at least, the establishment of senescence arrest' (Results and Discussion, Fig. 4). So the part attributed to this source that it does not support is 'for their maintenance' (ongoing maintenance of the established senescent state); the supported part is autophagy's role in establishing/quality of the senescence phenotype. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“DDR also participates in controlling regulation of the expression of immune ligands on senescent cells that mediate their recognition and consequent elimination by NK cells”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Sagiv et al, 2016 matched to “NKG2D ligands mediate immunosurveillance of senescent cells” (2016) source
The Introduction states that senescent cells present the NKG2D ligands MICA and ULBP2, enabling NK-cell recognition and elimination, and that a DNA damage response regulates ligand expression. The Discussion likewise attributes ligand regulation partly to the DNA damage response and says NKG2D receptor–ligand interaction is necessary for efficient elimination. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Cellular stress induced by persistent DDR is a central mechanism that drives senescence in aging and age‐related diseases”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Campisi, 2013 matched to “Aging, Cellular Senescence, and Cancer” (2013) source
The 'Genomic Damage' subsection (CELLULAR SENESCENCE: CAUSES) states that senescence-efficacious lesions generate persistent DDR signaling, distinct from the transient DDR of mild damage, and 'Activation of Tumor Suppressors' states that persistent DDR signaling appears to initiate the senescence growth arrest, accompanied by stress-responsive p38MAPK/PKC signaling and increased ROS. The aging/age-disease linkage is carried by the Introduction (senescence links multiple aging pathologies, degenerative and hyperplastic) and by SENESCENT CELLS: CHARACTERISTICS, which reports persistent DNA damage foci in aging mouse and primate tissues, plus 'genomic damage—a common cause of cellular senescence' (Immune Clearance). The source hedges some of this ('may senesce primarily', 'appears to initiate') and notes DDR-independent routes (p38MAPK hyperactivation), but it does treat persistent DDR as the central initiating mechanism, matching the claim's scope. (LLM, conf=0.82)
- Not checked yetcites Munoz‐Espin & Serrano, 2014
- Not checked yetcites Ovadya & Krizhanovsky, 2014 matched to “Senescent cells: SASPected drivers of age-related pathologies” (2014) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the signal intensity of 1,595 unique genes changed significantly in response to p21 knockdown in DIS cells compared to only 82 in growing cells (Fig 2C).”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > Molecular pathways activated after p21 knockdown in DIS cells
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 110 claims and to verify the 31 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence also is associated with upregulation of anti-apoptotic proteins of the BCL-2 family, particularly BCL-2, BCL-Xl, and BCL-W [14,15,143,144]”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [144]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“p21 upregulation has also been suggested as a mechanism that enables senescent cells to resist apoptosis, thereby facilitating their retention in tissues (Yosef et al, 2017).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Yosef et al, 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, p16 might not be a specific or sensitive marker for cellular senescence since not all p16 highly expressing (p16high) cells are necessarily senescent [4] and some senescent cells do not express p16 [5,6].”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Upregulation of the cell cycle inhibitor p21 contributes to apoptosis resistance, for example, by inhibiting p53-mediated apoptosis after DNA damage [256,257] and by preventing the cleavage of the apoptosis effector caspase-3 and the activation of the JNK pathway (both required for apoptosis) [144].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 knockout alleviates liver fibrosis
“JQuantification of Sirius Red staining presented in (H).”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 knockout alleviates liver fibrosis
“ISirius Red staining of DIS cells after transduction with sip21 and siCtrl.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 regulates the DNA damage response in senescent cells
“Each specimen was evaluated in triplicate. At least 50 cells were analyzed per replica”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Materials and Methods > Comet assay
“A minimum of 50 individual cells per sample were scored in duplicates.”
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · cited 1×
“Preprocessing was performed with the Robust Microarray Averaging algorithm (Irizarry et al , 2003).”
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Elimination of senescent cells may therefore allow better recovery of tissues, consistent with the finding that senescent cell elimination via transgenic techniques improves aging-associated phenotypes (Baker et al , 2011, 2016).”
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“…secretory phenotype (SASP) (Coppe et al , 2008), which reinforces senescence arrest in an autocrine manner (Acosta et al , 2008, 2013; Kuilman et al , 2008; Wajapeyee et al , 2008) and mediates immune surveillance of the senescent cells (Sagiv & Krizhanovsky, 2013; Sagiv et al…”
InfluentialNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 2×
“Elimination of senescent cells may therefore allow better recovery of tissues, consistent with the finding that senescent cell elimination via transgenic techniques improves aging-associated phenotypes (Baker et al , 2011, 2016).”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 3×
“…in the organism promoting local inflammation that drives tissue aging, tissue destruction, and potentially also tumorigenesis and metastasis in a cell non-autonomous manner (Krtolica et al , 2001; Campisi, 2013; Munoz-Espin & Serrano, 2014; Ovadya & Krizhanovsky, 2014; Salama et al , 2014).”
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“…accompanied by the p53 (TP53) target p21 (CDKN1A), inhibits cyclin-dependent kinases (CDKs), thereby preventing phosphorylation of the retinoblastoma protein (pRb) and thus in turn suppressing the expression of proliferation-associated genes (Narita et al , 2003, 2006; Collado et al , 2007).”
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“…termed the senescence-associated secretory phenotype (SASP) (Coppe et al , 2008), which reinforces senescence arrest in an autocrine manner (Acosta et al , 2008, 2013; Kuilman et al , 2008; Wajapeyee et al , 2008) and mediates immune surveillance of the senescent cells (Sagiv &…”
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 301–339 of 339
Kessai, F. (2024) · Papyrus : Institutional Repository (Université de Montréal) · doi:10.71781/28303
Mechanistic insights into age-associated chromosome mis-segregation and senescence
Vilares, M. B. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/5858-jj86
Semenov, D. V., Tatarnikova, I. S., Chesnokova, A. Y., Talyshev, V. A., Аркадьевна, З. М., & Logashenko, E. B. (2026) · Cells · doi:10.3390/cells15020115
“…and describe senescent-like cells (SnCs) within AdMer35 and AdMer43 cell populations, we used the AUCell algorithm with custom RNA markers chosen using literature data and the Enrichr “WikiPathways 2024 Human” library “Senescence Associated Secretory Phenotype SASP WP3391” (Table S1) [55–64].”
Phosphorylation level of the p21 PIP-box modulates interaction with PCNA in living cells
Melle, C., Hoffmann, B., Wiesenburg, A., & Biskup, C. U. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153508 · Cited by 1
Schwab, N. (2023) · TSpace (University of Toronto)
马, 继. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.163858
Colonic inflammatory response in a D-galactose-induced aging model: elevated IL-1β expression
Azaria, C., Susilowati, R., Sumiwi, Y. A. A., & Purnomosari, D. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10768-5
de Jong, D. (2018) · theses.fr (ABES) · doi:10.70675/27595e3bzbf8ez4196zb9b4z036b359e6b5c
Dissecting the non-cell autonomous impact of cellular senescence on cellular reprogramming
von Joest, M. (2019) · theses.fr (ABES) · doi:10.70675/01382339z05d9z4aacz911dz62afcc7c9191
Mechanisms of precocious ageing in a human progeroid syndrome
Molina, C. F. (2021) · theses.fr (ABES) · doi:10.70675/f78c9fa2z621cz48b6zbf00z1133c36b723a
Lier la méthylation de l'ADN et la sénescence dans les cellules cancéreuses
Chen, X. (2025) · theses.fr (ABES) · doi:10.70675/498e6681z2d9fz469cz876dz8902dda81cc6
Rôle de FAT10 dans la sénescence des hépatocytes et le développement de la NASH
Bernard, L. (2023) · theses.fr (ABES) · doi:10.70675/793b0b93z9794z42d4zb8dfz5f3d68268a9b
Transcriptional regulation in cardiovascular aging
Fan, Y., Song, C., Feng, F., Xun, Q., Lu, Y., & Li, C. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1752877
“…acetylation. p53 positively regulates p21 [a cyclin-dependent kinase (CDK) inhibitor], and p21 is a key factor in p53-mediated cell cycle arrest at the G1/S or G2/M phase. p21 inhibits cell apoptosis by binding to caspases, thereby promoting the maintenance of the cellular senescence state (26).”
Gan, L., You, Z., Tan, W., Feng, S., Cai, Y., Shi, X., Ma, X., Yu, J., & Pan, J. (2026) · PeerJ · doi:10.7717/peerj.21426
“CDKN1A is a central regulator of cell cycle progression, playing essential roles in cellular proliferation, differentiation, stress responses, and programmed cell death ( Yosef et al., 2017 ).”
Kunchur, A. (2025) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Cellular senescence in Crohn’s disease: a double-edged sword in intestinal fibrosis
Liu, J., & Yu, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1825690
“For example, CDK inhibitor p21 (CDKN1A) not only regulates senescence but also controls ECM component expression in fi brotic lung senescent cells, affecting their microenvironment (247, 248).”
P2Y12-AMPKα2 signaling contributes to cardiomyocyte senescence in doxorubicin-induced heart failure
Niu, Q., Wang, H. W., Zhao, M., Zhang, H., Hao, R., Liu, P., Guo, L., Chen, B., Xi, Y., Li, P., et al. (2026) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-026-05593-z
Whiteman, C. A. R. (2026) · Scientific Reports · doi:10.1038/s41598-026-60215-4
Senescent cells accumulate lipid droplets
Rachmian, N., Shmulevich, R., Akiva, H., Pokorná, Š., Dassa, B., Cherqui, U., Malitsky, S., Itkin, M., Kliger, B. A., Goliand, I., et al. (2026) · Aging · doi:10.18632/aging.206390 · Cited by 1
“We induced senescence in the BJ cells by exposure to the DNA-damage agent Etoposide, a well-established model for studying senescence in culture [43].”
Self-citationSriratanasak, N. (2024) · Chula Digiverse · doi:10.58837/chula.the.2024.1442
Huang, J., Chu, F., Feng, B., Chen, L., Cen, P., Wang, J., Qu, Y., Hong, L., Wu, F., Tian, H., et al. (2026) · Smart Molecules · doi:10.1002/smo2.70091
Sun, C., Muthusamy, P., Pattanimuthu, A., & Liu, M. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103315
Marchetta, P. (2024) · Lu Zone Ul (Laurentian University)
Dependance of doxorubicin efficacy of on p21 protein level in tumor cells
Zamkova, M. A., Bruter, A. V., Kubekina, M. V., & Tatarskiy, V. V. (2026) · Advances in molecular oncology · doi:10.17650/2313-805x-2026-13-2-85-93
CDKN1A expression correlates with telomere length in skeletal muscle of d-galactose–induced rats
Dewi, R., Breslim, Y., Handayani, M. D. N., & Siswanto, F. M. (2026) · Media Penelitian dan Pengembangan Kesehatan · doi:10.34011/jmp2k.v36i3.4560
PP4 deficiency drives airway epithelial senescence via the PERK-eIF2α-ATF4-p21 axis in severe asthma
Huang, Y.-T., Chen, C.-Y., Weng, C.-M., Wang, S., Hsu, S.-C., & Yang, F. (2026) · Inflammation Research · doi:10.1007/s00011-026-02378-4
Células Senescentes: ¿Cuál es su efecto e importancia?
Martínez, I., & López, M. (2023) · Dermatología Venezolana
Fillot, T. (n.d.) · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele
Sonntag, J., Preugschas, R.-L., Jazmati, D., Qin, N., Neuwahl, J., Matuschek, C., Remke, M., Budach, W., Hörner‐Rieber, J., & Sohn, D. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03404-4
“UW228-3 cells expressing mutated p53, however, do not induce p21 in substantial amounts, which would be essential for DNA damage-mediated senescence [48 – 51], and are eliminated by γ IR-mediated apoptosis.”
MELJEM, J. M. 3. G., & Palacios, V. R. E. (2022) · Repositorio del Tecnológico de Monterrey (Tecnológico de Monterrey)
Demeule, M., Currie, J.-C., Charfi, C., Zgheib, A., Cousineau, I., Lullier, V., Béliveau, R., Marsolais, C., & Annabi, B. (2024) · doi:10.3389/fimmu.2024.1355945.s003
Yang, Y., Mihajlovic, M., Valentijn, F., Nguyen, T. Q., Goldschmeding, R., & Masereeuw, R. (2022) · doi:10.3389/fphar.2022.791612.s001
Metadata
- Authors
- Yosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Krizhanovsky, Valery
- Venue
- The EMBO Journal
- Published
- 2017-06-12
- Volume
- 36
- Issue
- 15
- Pages
- 2280-2295
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC5538795
- OpenAlex
- W2624008928
- Cited by
- 293
- References
- 58
- Citations by year
- 2026: 24 · 2025: 38 · 2024: 39 · 2023: 41 · 2022: 36 · 2021: 50 · 2020: 27 · 2019: 26 · 2018: 11 · 2017: 1
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Research Council (309688)
- Israel Science Foundation (634/15)
- Bruce Kanter Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, p21, DNA damage response, ATM, NF-κB signaling, JNK signaling, caspase signaling, TNF-α, liver stellate cells, liver fibrosis, collagen synthesis, aging
- MeSH terms
- Animals, Cell Line, Cell Survival, DNA Damage, Gene Expression Regulation, Humans, Caspases, MAP Kinase Signaling System, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.